What it sells
Microorganisms as programmable factories for industrial ingredients.
Business model breakdown
Economics: what it saves and how it charges
Ingredient sales from in-house fermentation and downstream bioprocessing; funded by 7M EUR seed (March 2026) and 3.3M EUR pre-seed.
Distribution: how it reaches customers
Direct B2B inquiry ("Contact us").
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-03-03 | — | €7M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.